Roivant and Pharvaris surge to record highs on positive trial results
Roivant Sciences (ROIV) and Pharvaris (PHVS) hit all-time highs after reporting positive results for experimental therapies across different trial phases. ROIV was up more than 20% and PHVS was up nearly 8%.
Shares of Roivant Sciences (ROIV) and Pharvaris (PHVS) jumped to all-time highs after the biotech firms reported positive results for their experimental therapies in different trial phases. At the time of writing, ROIV shares were up by more than 20% and PHVS stock was up nearly 8%. C. Wainwr…